A Phase 2, Prospective, Interventional, Open-Label, Multi-Site, Extension Study to Assess the Long-Term Safety and Tolerability of TAK-935 (OV935) as Adjunctive Therapy in Patients with Rare Epilepsy (ENDYMION)

Project: Research

StatusActive
Effective start/end date8/10/197/10/24

Keywords

  • clinical trial
  • treatment efficacy
  • epilepsy
  • treatment safety